FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2148910366> ?p ?o ?g. }

• W2148910366 endingPage "317" @default.
• W2148910366 startingPage "313" @default.
• W2148910366 abstract "Owing to their massive use, Staphylococcus epidermidis has recently developed significant resistance to several antibiotics, and became one of the leading causes of hospital-acquired infections. Current antibiotics are typically ineffective in the eradication of bacteria in biofilm-associated persistent infections. Accordingly, the paucity of effective treatment against cells in this mode of growth is a key factor that potentiates the need for new agents active in the prevention or eradication of biofilms. Daptomycin and linezolid belong to the novel antibiotic therapies that are active against gram-positive cocci. On the other hand, rifampicin has been shown to be one of the most potent, prevalent antibiotics against S. epidermidis biofilms. Therefore, the main aim of this study was to study the susceptibility of S. epidermidis biofilm cells to the two newer antimicrobial agents previously mentioned, and compare the results obtained with the antimicrobial effect of rifampicin, widely used in the prevention/treatment of indwelling medical device infections. To this end the in vitro activities of daptomycin, linezolid, and rifampicin on S. epidermidis biofilms were accessed, using these antibiotics at MIC and peak serum concentrations. The results demonstrated that at MIC concentration, rifampicin was the most effective antibiotic tested. At peak serum concentration, both strains demonstrated similar susceptibility to rifampicin and daptomycin, with colony-forming units (CFUs) reductions of approximately 3-4 log(10), with a slightly lower response to linezolid, which was also more strain dependent. However, considering all the parameters studied, daptomycin was considered the most effective antibiotic tested, demonstrating an excellent in vitro activity against S. epidermidis biofilm cells. In conclusion, this antibiotic can be strongly considered as an acceptable therapeutic option for S. epidermidis biofilm-associated infections and can represent a potential alternative to rifampicin in serious infections where rifampicin resistance becomes prevalent." @default.
• W2148910366 created "2016-06-24" @default.
• W2148910366 creator A5008068226 @default.
• W2148910366 creator A5012398412 @default.
• W2148910366 creator A5014366472 @default.
• W2148910366 creator A5032186443 @default.
• W2148910366 creator A5072102749 @default.
• W2148910366 creator A5076567294 @default.
• W2148910366 date "2011-07-15" @default.
• W2148910366 modified "2023-09-29" @default.
• W2148910366 title "In vitro Activity of Daptomycin, Linezolid and Rifampicin on Staphylococcus epidermidis Biofilms" @default.
• W2148910366 cites W1688226517 @default.
• W2148910366 cites W1967941292 @default.
• W2148910366 cites W1974658379 @default.
• W2148910366 cites W2000120673 @default.
• W2148910366 cites W2011976614 @default.
• W2148910366 cites W2014892817 @default.
• W2148910366 cites W2017152369 @default.
• W2148910366 cites W2075847190 @default.
• W2148910366 cites W2099277918 @default.
• W2148910366 cites W2100287000 @default.
• W2148910366 cites W2107249444 @default.
• W2148910366 cites W2109899161 @default.
• W2148910366 cites W2114144364 @default.
• W2148910366 cites W2115933619 @default.
• W2148910366 cites W2120575175 @default.
• W2148910366 cites W2143661366 @default.
• W2148910366 cites W2144440398 @default.
• W2148910366 cites W2144706728 @default.
• W2148910366 cites W2153932106 @default.
• W2148910366 cites W2155310840 @default.
• W2148910366 cites W2162213923 @default.
• W2148910366 cites W2163581302 @default.
• W2148910366 cites W2169207123 @default.
• W2148910366 cites W4230690150 @default.
• W2148910366 doi "https://doi.org/10.1007/s00284-011-9980-7" @default.
• W2148910366 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21761219" @default.
• W2148910366 hasPublicationYear "2011" @default.
• W2148910366 type Work @default.
• W2148910366 sameAs 2148910366 @default.
• W2148910366 citedByCount "35" @default.
• W2148910366 countsByYear W21489103662012 @default.
• W2148910366 countsByYear W21489103662013 @default.
• W2148910366 countsByYear W21489103662014 @default.
• W2148910366 countsByYear W21489103662015 @default.
• W2148910366 countsByYear W21489103662016 @default.
• W2148910366 countsByYear W21489103662017 @default.
• W2148910366 countsByYear W21489103662018 @default.
• W2148910366 countsByYear W21489103662019 @default.
• W2148910366 countsByYear W21489103662020 @default.
• W2148910366 countsByYear W21489103662021 @default.
• W2148910366 countsByYear W21489103662023 @default.
• W2148910366 crossrefType "journal-article" @default.
• W2148910366 hasAuthorship W2148910366A5008068226 @default.
• W2148910366 hasAuthorship W2148910366A5012398412 @default.
• W2148910366 hasAuthorship W2148910366A5014366472 @default.
• W2148910366 hasAuthorship W2148910366A5032186443 @default.
• W2148910366 hasAuthorship W2148910366A5072102749 @default.
• W2148910366 hasAuthorship W2148910366A5076567294 @default.
• W2148910366 hasBestOaLocation W21489103662 @default.
• W2148910366 hasConcept C2777949923 @default.
• W2148910366 hasConcept C2778607973 @default.
• W2148910366 hasConcept C2778651397 @default.
• W2148910366 hasConcept C2778980435 @default.
• W2148910366 hasConcept C2779489039 @default.
• W2148910366 hasConcept C2781414143 @default.
• W2148910366 hasConcept C4937899 @default.
• W2148910366 hasConcept C501593827 @default.
• W2148910366 hasConcept C523546767 @default.
• W2148910366 hasConcept C54355233 @default.
• W2148910366 hasConcept C58123911 @default.
• W2148910366 hasConcept C71924100 @default.
• W2148910366 hasConcept C86803240 @default.
• W2148910366 hasConcept C89423630 @default.
• W2148910366 hasConceptScore W2148910366C2777949923 @default.
• W2148910366 hasConceptScore W2148910366C2778607973 @default.
• W2148910366 hasConceptScore W2148910366C2778651397 @default.
• W2148910366 hasConceptScore W2148910366C2778980435 @default.
• W2148910366 hasConceptScore W2148910366C2779489039 @default.
• W2148910366 hasConceptScore W2148910366C2781414143 @default.
• W2148910366 hasConceptScore W2148910366C4937899 @default.
• W2148910366 hasConceptScore W2148910366C501593827 @default.
• W2148910366 hasConceptScore W2148910366C523546767 @default.
• W2148910366 hasConceptScore W2148910366C54355233 @default.
• W2148910366 hasConceptScore W2148910366C58123911 @default.
• W2148910366 hasConceptScore W2148910366C71924100 @default.
• W2148910366 hasConceptScore W2148910366C86803240 @default.
• W2148910366 hasConceptScore W2148910366C89423630 @default.
• W2148910366 hasIssue "3" @default.
• W2148910366 hasLocation W21489103661 @default.
• W2148910366 hasLocation W21489103662 @default.
• W2148910366 hasLocation W21489103663 @default.
• W2148910366 hasLocation W21489103664 @default.
• W2148910366 hasOpenAccess W2148910366 @default.
• W2148910366 hasPrimaryLocation W21489103661 @default.
• W2148910366 hasRelatedWork W122456818 @default.
• W2148910366 hasRelatedWork W1579162802 @default.
• W2148910366 hasRelatedWork W2018382434 @default.

• next